Versant Capital Management, Inc - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$500
-13.0%
240.0%0.00%
Q2 2023$575
-26.3%
24
-51.0%
0.00%
Q4 2022$780
-22.0%
490.0%0.00%
Q3 2022$1,00049
+122.7%
0.00%
Q3 2021$0
-100.0%
22
-83.8%
0.00%
-100.0%
Q2 2021$3,000
+200.0%
136
+338.7%
0.00%
Q4 2020$1,0000.0%31
-16.2%
0.00%
Q3 2020$1,0000.0%370.0%0.00%
Q2 2020$1,0000.0%370.0%0.00%
-100.0%
Q1 2020$1,000370.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders